A glimmer of hope: New weapon in the fight against liver diseases

The information presented in this study is primarily positioned to benefit scientists and experts in regenerative medicine where new tools strategies to treat liver diseases are required. The evidence presented in this manuscript illustrates exploiting small extracellular vesicles (sEVs) derived from interferon-γ (IFN-γ) pre-conditioned MSCs (γ-sEVs) can be a foundational formulation for a therapeutic solution that will be accessible, cost effective, and efficacious in treating liver diseases.